Physician
Psychiatry
Dr. Benoit H. Mulsant, MD
|
|
Give Review
Benoit H. Mulsant works in the field of Psychiatry. Doctor Benoit H. Mulsant, MD is a published doctor. He has 100 publications published. The most current publication "Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial."
Publications
- Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
- Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment.
- Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
- Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.
- Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review.
- Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial.
- Social support in late life mania: GERI-BD.
- Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study.
- Measuring treatment response in psychotic depression: The Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
- A Gender Analysis of the Study of Pharmacotherapy of Psychotic Depression (STOP-PD): Gender and Age as Predictors of Response and Treatment-Associated Changes in Body ...
- Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.
- Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?
- Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy.
- Dynamic Prediction of Treatment Response in Late-Life Depression.
- Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation.
- Social inequalities in depression and suicidal ideation among older primary care patients.
- Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
- Incorporating temporal features of repeatedly measured covariates into tree-structured survival models.
- A Comparison of the E-BEHAVE-AD, NBRS, and NPI in Quantifying Clinical Improvement in the Treatment of Agitation and Psychosis Associated With Dementia.
- Treatment resistant schizophrenia and response to antipsychotics: A review.
- Use of Lithium in the Treatment of Bipolar Disorder in Late-Life.
- A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
- Exploring the effect of inducing long-term potentiation in the human motor cortex on motor learning.
- Problem-solving therapy reduces disability more than supportive therapy in older adults with major depression and executive dysfunction.
- Neurobiology of delusions in Alzheimer's disease.
- Acupuncture for the treatment of major depressive disorder: a randomized controlled trial.
- Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report.
- The ZNF804A Gene: Characterization of a Novel Neural Risk Mechanism for the Major Psychoses.
- Age and Sex Impact Clozapine Plasma Concentrations in Inpatients and Outpatients With Schizophrenia.
- Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections.
- Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
- The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
- Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
- Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidep...
- The role of the corpus callosum in transcranial magnetic stimulation induced interhemispheric signal propagation.
- Clozapine and global cognition in schizophrenia.
- Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial.
- Age-related decline in white matter tract integrity and cognitive performance: A DTI tractography and structural equation modeling study.
- Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia.
- Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.
- D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia.
- Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients.
- Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
- Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.
- Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography.
- Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms.
- Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms.
- Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
- High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression.
- Biomarkers in geriatric psychiatry: searching for the holy grail?
- Correlates of suicidality among patients with psychotic depression.
- Anticholinergic activity of 107 medications commonly used by older adults.
- Empirically derived decision trees for the treatment of late-life depression.
- Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan.
- Twelve-year depressive symptom trajectories and their predictors in a community sample of older adults.
- Medical burden in late-life bipolar and major depressive disorders.
- Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
- A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
- Biomarkers in geriatric psychiatry.
- Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
- Cognitive impairment in late-life generalized anxiety disorder.
- Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy.
- Perception gap in quality-of-life ratings: an empirical investigation of nursing home residents and caregivers.
- Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.
- The evidence for electroconvulsive therapy (ECT) in the treatment of severe late-life depression. ECT: the preferred treatment for severe depression in late life.
- Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
- Impact of prior treatment exposure on response to antidepressant treatment in late life.
- Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
- Pressure ulcer prevention in black and white nursing home residents: A QI initiative of enhanced ability, incentives, and management feedback.
- Speed of improvement in sleep disturbance and anxiety compared with core mood symptoms during acute treatment of depression in old age.
- Discrepancies in information provided to primary care physicians by patients with and without dementia: the Steel Valley Seniors Survey.
- Persistence of neuropsychologic deficits in the remitted state of late-life depression.
- What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?
- Maintenance treatment of major depression in old age.
- Ability, incentives, and management feedback: organizational change to reduce pressure ulcers in a nursing home.
- Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment.
- Elevation in plasma Abeta42 in geriatric depression: a pilot study.
- Predictors of adequacy of depression management in the primary care setting.
- Trajectories of treatment response in late-life depression: psychosocial and clinical correlates.
- Predictors of remission after electroconvulsive therapy in unipolar major depression.
- Somatic symptoms in late-life anxiety: treatment issues.
- Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia.
- Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances.
- Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation.
- A pilot study of standardized treatment in geriatric bipolar disorder.
- Body pain and treatment response in late-life depression.
- Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder.
- Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
- Serotonin 1A receptor binding and treatment response in late-life depression.
- Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
- Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
- Neuropathologic correlates of late-onset major depression.
- Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.
- Actors' portrayals of depression to test interrater reliability in clinical trials.
- Concurrent psychiatric diagnoses by age and race among persons with bipolar disorder.
- Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?
- Pharmacotherapy of bipolar disorder in old age: review and recommendations.
- The nature and determinants of neuropsychological functioning in late-life depression.
- Family caregiver functioning in late-life bipolar disorder.
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Nicholas W. Carosella, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rolf G. Jacob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney J. Williams, MD |
|
|
Dr. Judith A. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Flanders, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Rancurello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul U. Bulgarelli, DO |
|
|
Dr. Jonathan M. Himmelhoch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy J. Minshew, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Konasale M. Prasad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Sweet, MD |
|
|
Dr. Daniel J. Cohen, MD |
|
|
Dr. Lalithkumar Solai, MD |
|
|
Dr. John W. Kasckow, MD
This Doctor is OpenDoctor Recommended.
|